Skip to the page

Data / Drug companies / Madison One Acme Inc

Madison One Acme Inc: 18 products in the FDA NDC directory, labeler code 55614

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Madison One Acme Inc (labeler code 55614) lists 18 products in the FDA National Drug Code Directory, covering 9 finished drugs by generic name. By type: 18 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on June 1, 2023.

The request: Watch Madison One Acme Inc (FDA labeler code 55614): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
55614
Products in commercial distribution
18
Packages
23
Finished drugs by generic name
9
Prescription products
0
Over the counter products
18
Flagged as original packager
18 of 18 products that carry the flag
Started marketing in the last 12 months
0
Products with a marketing end date set
1
Earliest marketing start
July 26, 2019
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs18100%

Products by type

TypeProductsShare
Over the counter drugs18100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Camphor, menthol, methyl salicylate636
Menthol and camphor37
Camphor and menthol38
Capsaicin166
Calamine, petrolatum and phenylephrine hydrochloride11
Clotrimazole198
Camphor and methyl salicylate11
Camphor, menthol, and methyl salicylate14
Camphor, capsaicin, and methyl salicylate11

Dosage forms

Dosage formProductsShare
Oil738.9%
Patch422.2%
Ointment316.7%
Plaster316.7%
Liniment15.6%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Yulam die da wan hua pain relieving55614-740OilOver the counter monograph drugsJune 1, 2023
Hei gui pain relieving55614-711OilOver the counter monograph drugsMarch 30, 2021
Zang hong hua pain relieving55614-641OilOver the counter monograph drugsMarch 30, 2021
Shu jin huo luo pain relieving55614-670OilOver the counter monograph drugsMarch 23, 2021
E mei shan medicated55614-730PlasterOver the counter monograph drugsFebruary 16, 2021
Huo luo pain relieving55614-671OilOver the counter monograph drugsDecember 18, 2020
Qian li zhui feng pain relieving55614-690OilOver the counter monograph drugsOctober 27, 2020
Wu yang brand pain relieving medicated55614-700PlasterOver the counter monograph drugsAugust 31, 2020
Josephs lion pain relieving55614-680OilOver the counter monograph drugsJune 4, 2020
Neck and lumbar pain relieving balm55614-661OintmentOver the counter monograph drugsMay 21, 2020
701 dieda zhengtong yaogao medicated55614-620PlasterOver the counter monograph drugsMay 4, 2020
Hua tuo xian gao antifungal55614-650OintmentOver the counter monograph drugsApril 1, 2020
Extra strength hua tuo pain relief55614-630PatchOver the counter monograph drugsApril 1, 2020
Fargelin hemorrhoidal55614-610OintmentOver the counter monograph drugsNovember 27, 2019
Lung Choy Shung Pain Relief Liquid55614-600LinimentOver the counter monograph drugsNovember 25, 2019
Solstice Capsaicin Patch Hot55614-410PatchOver the counter monograph drugsSeptember 18, 2019
Solstice Pain Relieving55614-310PatchOver the counter monograph drugsJuly 29, 2019
Solstice Pain Relieving55614-210PatchOver the counter monograph drugsJuly 26, 2019

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.